Navalit (Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride)

Doxylamine hydrogen succinate, the active ingredient in Navalit, is a H1 receptor antagonist presented as an oral tablet for oral use. It is combined with pyridoxine hydrochloride to treat nausea and vomiting of pregnancy (morning sickness) in pregnant women. GNH USA supplies Navalit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Navalit is an antihistamine‑vitamin B6 combination used to manage nausea‑related conditions. - Morning sickness (NVP): reduces the frequency and severity of nausea and vomiting in pregnant women. - Motion sickness: helps prevent nausea associated with travel by land, sea, or air. - Post‑operative nausea and vomiting: may be used as part of a regimen to control nausea after surgery.

Navalit may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a sticky sensation. - Constipation: slowed intestinal motility. - Blurred vision: temporary difficulty focusing. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hallucinations or confusion: altered mental status. - Cardiac arrhythmia: irregular heartbeat. - Stevens‑Johnson syndrome: severe skin blistering. - Seizures: uncontrolled electrical activity in the brain.

Before using Navalit, consider the following safety measures. - Pregnancy risk assessment: use only if the expected benefit outweighs potential risk. - Alcohol avoidance: do not consume alcoholic beverages while taking the product. - Hepatic impairment: dose may need adjustment in liver disease. - Driving and machinery: avoid operating vehicles or heavy equipment if drowsy. - Elderly monitoring: start with the lowest effective dose and watch for increased sedation. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Navalit can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Alcohol: potentiates central nervous system depression. - Other CNS depressants (e.g., benzodiazepines): may cause excessive sedation. - MAO inhibitors: risk of hypertensive crisis. - Anticholinergic agents: increase anticholinergic burden. - Additional antihistamines: may intensify drowsiness.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible serotonin syndrome. - Tricyclic antidepressants: may enhance anticholinergic effects. - Opioid analgesics: additive sedation. - Antacids containing aluminum or magnesium: may affect absorption. - CYP450 inhibitors: could raise plasma levels of doxylamine.